After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
GERN belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Geron Corp is $910.79M. A total of 7.84 million shares were traded on the day, compared to an average of 15.46M shares.
In the most recent transaction, Samuels Scott Alan bought 15,000 shares of GERN for 1.61 per share on Feb 27 ’25. After the transaction, the EVP, Chief Legal Officer now owns 26,682 company shares. In a previous transaction on Feb 27 ’25, SCARLETT JOHN A bought 12,500 shares at 1.76 per share. GERN shares that Chairman, President and CEO owns now total 12,500.
Among the insiders who bought shares, Ziegler James acquired of 100,000 shares on Feb 27 ’25 at a per-share price of $1.60. This resulted in the EVP, Chief Commercial Officer holding 100,000 shares of GERN after the transaction. In another insider transaction, GRETHLEIN ANDREW J sold 674,348 shares at $4.56 per share on Jul 08 ’24. Company shares held by the EVP, Chief Operating Officer now total 0.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, GERN has a high of $5.34 and a low of $1.17.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. GERN’s latest balance sheet shows that the firm has $183.72M in Cash & Short Term Investments as of fiscal 2021. There were $55.00M in debt and $45.52M in liabilities at the time. Its Book Value Per Share was $0.46, while its Total Shareholder’s Equity was $126.42M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for GERN is Buy with a score of 4.50.
